Answers are grounded in this paper and cite their sources.
Exosomes are promising nanoscale agents that can serve both as efficient drug delivery carriers and as bioactive therapeutics with intrinsic biological functions. Yet their clinical translation is hindered by formulation-dependent instability and an incomplete understanding of excipient–membrane interactions. Here, we systematically and, to our knowledge, for the first time dissect how nonionic surfactants govern exosome stability, membrane organization, and bioactivity across sub- to supra-critical micelle concentration regimes. Using bovine exosomes as a model, we verify that exosomes in phosphate-buffered saline are intrinsically metastable, undergoing progressive interfacial reorganization and particle loss even at 4 °C. Surfactants exhibit distinct, structure-dependent effects: polysorbates (PS20, PS80) reduce hydrodynamic size but accelerate particle loss, whereas poloxamer 188 (P188) preserves both size and concentration. Membrane analysis shows that polysorbates increase lipid fluidity, potentially through interactions with the lipid bilayer. P188 may act through preferential surface association with limited effects on the measured lipid packing environment. Functionally, PS20 enhances cellular uptake at the expense of structural integrity, whereas P188 maintains vesicle integrity with moderate functional gain. Across multiple exosome sources, these trends are conserved, demonstrating the generality of the underlying mechanisms. Together, our results establish a mechanistic framework linking surfactant structure, concentration, and membrane interaction to both physicochemical stability and biological performance, providing actionable design principles for exosome formulations.
No takes yet. Share an insight, caveat, or question.
Lv et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: